Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.09 - $1.67 $17.2 Million - $26.4 Million
-15,792,692 Reduced 74.6%
5,377,113 $5.86 Million
Q4 2021

Feb 14, 2022

SELL
$3.24 - $5.18 $2.22 Million - $3.55 Million
-686,227 Reduced 3.14%
21,169,805 $71.3 Million
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $18.1 Million - $26.8 Million
-4,597,390 Reduced 17.38%
21,856,032 $111 Million
Q1 2021

May 17, 2021

SELL
$5.03 - $8.8 $7.74 Million - $13.5 Million
-1,538,339 Reduced 5.5%
26,453,422 $164 Million
Q4 2020

Feb 16, 2021

SELL
$4.04 - $5.31 $16.3 Million - $21.4 Million
-4,027,106 Reduced 12.58%
27,991,761 $137 Million
Q3 2020

Nov 16, 2020

SELL
$3.64 - $7.76 $9.02 Million - $19.2 Million
-2,477,818 Reduced 7.18%
32,018,867 $135 Million
Q4 2019

Feb 14, 2020

SELL
$13.94 - $24.12 $98.2 Million - $170 Million
-7,047,603 Reduced 16.96%
34,496,685 $740 Million
Q2 2019

Aug 14, 2019

SELL
$16.27 - $20.51 $27.1 Million - $34.2 Million
-1,666,171 Reduced 3.86%
41,544,288 $806 Million
Q1 2019

May 15, 2019

BUY
$12.61 - $22.33 $7.79 Million - $13.8 Million
617,635 Added 1.45%
43,210,459 $897 Million
Q4 2018

Feb 13, 2019

BUY
$12.41 - $22.98 $106 Million - $196 Million
8,523,315 Added 25.02%
42,592,824 $580 Million
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $27.9 Million - $185 Million
11,400,000 Added 50.29%
34,069,509 $554 Million
Q3 2017

Nov 14, 2017

BUY
$3.03 - $3.72 $68.7 Million - $84.3 Million
22,669,509
22,669,509 $79.3 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.